Global Flow Cytometry System Market by Technology (Cell-based Flow Cytometry System, Bead Based Flow Cytometry System), Products and Services (Reagents and Consumables, Instruments, Software, Services, and Accessories), Applications (Research Applications, Clinical Applications, and Industrial Applications), Research Applications (Pharmaceuticals and Biotechnology, Immunology, Cell Sorting, Apoptosis, Cell Cycle Analysis, Cell Viability, Cell Counting, and Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2020 – 2027
Flow Cytometry System Market Outlook
The global flow cytometry system market was valued at USD 4,298.1 Million in 2019 and is projected to reach USD 9,452.6 Million by 2027, expanding at a CAGR of 10.0% during the forecast period. Flow cytometry is technique, which is used to measure the physical and chemical characteristics of cells.
Flow cytometry systems are the instruments, which are used for analyzing the quantitative of cells and for analyzing chromosomes, m-RNA, recombinant proteins, and other molecules, which are suspended in a fluid. Flow cytometry technique is based on the principle of the measurement of scattering of light by the particles. The fluorescence light is passed through the cell. The deflection of the light occurs, according to the complexity and size of the particle.
Forward-scattered light (FSC), and side-scattered light (SSC) are two methods of deflecting the light. The measurements of FSC and SSC are used for the differentiation of cell types in a heterogeneous cell suspension, while fluorescent markers are used for determining the proteins or nucleic acids. Fluorescence pattern of each cell suspension, which are mixed with FSC and SSC, can be used to identify the cells and to count their percentage.
For the detection of specific antibodies, cells are coated with fluorochrome-conjugated antibodies specific to the surface markers present on different cells. Flow cytometry techniques are used for identifying hematological malignancies. Cell size, granularity of the cell, and intracellular proteins can be identified using flow cytometry. Flow cytometry systems are used for precise analysis of small population of cells at high speed.
Flow Cytometry System Market Dynamics
Drivers
- Increased Use of Artificial Intelligence (AI) in Flow Cytometry Systems
The advent of new technology, has led to the adoption of the artificial intelligence (AI) for the detection and separation of the cells, molecules, and deoxyribonucleic acid (DNA), using a software, which is used in the flow cytometry systems process. AI is used in analyzing the images, and also interprets the complex data. Artificial intelligence uses programs and algorithms for the separation and analysis of cells.
AI, using the deep learning algorithms, simplifies the multimodal images, and reduces the variability in the data. The reduction in the variability in the data, enhances the quality of the data. The use of imaging flow cytometry systems combines brightfield, darkfield, and fluorescence-based detection all in one platform.
AI, finds its use in several applications, including, studies designed to monitor multiple subcellular compartments, or to locate and quantify the distribution of signaling molecules on, in, or between cells. Technological advancements and rise in the adoption of the AI in biotechnology and pharmaceutical industries are some of the factors, which boosts the adoption of AI in flow cytometry.
- Increase in Government Funding for Pharmaceutical and Biotechnology Companies
Governments are investing in research for the development of novel drugs and techniques for determining vaccines and drugs, thus boosting research and development (R&D) in the pharmaceutical and biotechnology industries. The investments boost the development of innovative products. Several research biotechnology and pharmaceutical companies have installed flow cytometers for the detection of recombinant proteins, and cell cycles.
Government investments reduce the burden on drug manufacturing companies, thus boosting the adoption of the flow cytometers. The government of the UK, has increased funding for R&D. The government is focusing on the development of new drugs for biosimilars and personalized medicines, which boost the adoption of flow cytometers for the determination of mechanism of action of the drugs.
Restrains
- High Costs of Flow Cytometry Systems
Flow cytometers are widely used in pharmaceutical and biotechnology companies, for the manufacturing of drugs. Flow cytometers are used for the monitoring of diseases and are used in the diagnostic centers and hospitals. High costs of the flow cytometers is one of the major factor, which hampers the demand for the flow cytometers. Large amount of capital is required for the purchase of the flow cytometers.
Several companies have funding limitations, which hampers the demand for the flow cytometers. Costs of the reagents, which are used for the detection of antibodies, are also high, which hampers the demand for the flow cytometers. These are some of the factors, which hinders the demand for the flow cytometers.
- Dearth of Skilled Professionals
Dearth of skilled personnel is one of the major factors which hampers the market. Flow Cytometry Systems requires qualified personnel for analysis of the molecules, during the flow cytometry process. Skilled personnel is required for the implementation of new techniques.
However, several people are unqualified or under skilled for the processes, thus hampering the market. Several workers are unaware of the process and this may have an impact on the final products. The dearth of skilled labors is among the major factor, which hampers the adoption of glow cytometers in research institutes and organizations.
Flow Cytometry System Market Segmental Outlook
On the basis of technology, the market is segmented into cell-based flow cytometry system, and bead- based flow cytometry systems. The cell-based flow cytometry systems accounted for 78.9% share of the market in 2019.
The rapid growth of the segment is attributed to the rise in the demand for the analysis of the cells, and identification of the cell population which are some of the factors, which contributes for the growth of the segment. Additionally, the cell-based flow cytometry system is widely available and convenient to use, which is one of the factors, which contributes for the growth of the market.
In terms of products and services, the global flow cytometry systems market is divided into reagents and consumables, instruments, services, software, and accessories. The instruments segment is sub-segmented into cell analyzers and cell sorters. Reagents, and consumables segment is anticipated to expand at a CAGR of 10.4% during the forecast period. Rise in the use of the reagents, and consumables, for the detection of the antibodies, which are some of the factors, which contributes for the demand for the reagents and consumables.
Based on applications, the global flow cytometry systems market is divided into research applications, immunology, clinical applications, and industrial applications. The research applications segment is further segregated into pharmaceutical and biotechnology, drug discovery, stem cell research, and in-vitro toxicity.
The pharmaceutical and biotechnology segment is anticipated to account for a significant share of the market during the forecast period, while the drug discovery segment is estimated to expand at a substantial CAGR during the forecast period.
Based on research applications, the market is segmented into cancer diagnostics, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications. Cancer diagnostic segment is expected to have a significant share of the market, owing to the rise in the prevalence of cancer, which has led to the rise in the adoption of the flow cytometry systems for the prognosis of the diseases.
In terms of end-users, the global flow cytometry systems market is segregated into commercial organizations, hospitals, academic institutes, and clinical testing labs. The clinical testing labs segment is projected to constitute a large share of the market during the forecasts period, while the hospitals segment is anticipated to expand at significant pace during the forecast period.
Flow cytometry systems techniques is used for the analysis of the diseases. Flow cytometers are used to diagnose various types of cancer, which in turn, boost their adoption in the hospitals.
Flow Cytometry System Market Regional Outlook
In terms of regions, the global flow cytometry system market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in the Asia Pacific is projected to expand at a CAGR of 10.9% during the forecast period. Rise in presence of several manufacturers, is thereby boosting the growth of the flow cytometry system market in Asia Pacific.
Key Benefits for Industry Participants & Stakeholders
- In-depth Analysis of the Global Flow cytometry system Market
- Historical, Current and Projected Market Size in terms of Value
- Potential & Niche Segments and Regions Exhibiting Promising Growth Covered
- Industry Drivers, Restraints and Opportunities Covered in the Study
- Recent Industry Trends and Developments
- Competitive Landscape & Strategies of Key Players
- Neutral Perspective on Global Flow cytometry system Market Performance
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Flow Cytometry System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Flow Cytometry System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Flow Cytometry System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Flow Cytometry System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Flow Cytometry System Market Size & Forecast, 2017-2027
4.5.1 Flow Cytometry System Market Size and Y-o-Y Growth
4.5.2 Flow Cytometry System Market Absolute $ Opportunity
4.6 Pricing Analysis & Forecast, By Technology, 2017-2027
4.7 Global Flow Cytometry System Market: Impact Of Key Regulations
Chapter 5 Global Flow Cytometry System Market Analysis and Forecast By Technology
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities By Technology
5.1.2 Basis Point Share (BPS) Analysis By Technology
5.1.3 Absolute $ Opportunity Assessment By Technology
5.2 Flow Cytometry System Market Size Forecast By Technology
5.2.1 Cell-based Flow Cytometry
5.2.2 Bead-based Flow Cytometry
5.3 Market Attractiveness Analysis By Technology
Chapter 6 Global Flow Cytometry System Market Analysis and Forecast By Product and Service
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities By Product and Service
6.1.2 Basis Point Share (BPS) Analysis By Product and Service
6.1.3 Absolute $ Opportunity Assessment By Product and Service
6.2 Flow Cytometry System Market Size Forecast By Product and Service
6.2.1 Reagents and Consumables
6.2.2 Instruments
6.2.2.1 Cell Analyzers
6.2.2.1.1 High-range
6.2.2.1.2 Mid-range
6.2.2.1.3 Low-range
6.2.2.2 Cell Sorters
6.2.2.2.1 High-range
6.2.2.2.2 Mid-range
6.2.2.2.3 Low-range
6.2.3 Services
6.2.4 Software
6.2.5 Accessories
6.3 Market Attractiveness Analysis By Product and Service
Chapter 7 Global Flow Cytometry System Market Analysis and Forecast By Application
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities By Application
7.1.2 Basis Point Share (BPS) Analysis By Application
7.1.3 Absolute $ Opportunity Assessment By Application
7.2 Flow Cytometry System Market Size Forecast By Application
7.2.1 Research Applications
7.2.1.1 Pharmaceuticals and Biotechnology
7.2.1.1.1 Drug Discovery
7.2.1.1.2 Stem Cell Research
7.2.1.1.3 In Vitro Toxicity Testing
7.2.1.2 Immunology
7.2.1.3 Cell Sorting
7.2.1.4 Apoptosis
7.2.1.5 Cell Cycle Analysis
7.2.1.6 Cell Viability
7.2.1.7 Cell Counting
7.2.1.8 Other
7.2.2 Research Applications
7.2.2.1 Clinical Applications
7.2.2.2 Cancer Diagnostics
7.2.2.3 Hematology
7.2.2.4 Immunodeficiency Diseases
7.2.2.5 Organ Transplantation
7.2.2.6 Other Clinical Applications
7.2.3 Industrial Applications
7.3 Market Attractiveness Analysis By Application
Chapter 8 Global Flow Cytometry System Market Analysis and Forecast By End-user
8.1 Introduction
8.1.1 Key Market Trends & Growth Opportunities By End-user
8.1.2 Basis Point Share (BPS) Analysis By End-user
8.1.3 Absolute $ Opportunity Assessment By End-user
8.2 Flow Cytometry System Market Size Forecast By End-user
8.2.1 Commercial Organizations
8.2.2 Hospitals
8.2.3 Academic Institutes
8.2.4 Clinical Testing Labs
8.3 Market Attractiveness Analysis By End-user
Chapter 9 Global Flow Cytometry System Market Analysis and Forecast by Region
9.1 Introduction
9.1.1 Key Market Trends & Growth Opportunities by Region
9.1.2 Basis Point Share (BPS) Analysis by Region
9.1.3 Absolute $ Opportunity Assessment by Region
9.2 Flow Cytometry System Market Size Forecast by Region
9.2.1 North America
9.2.2 Europe
9.2.3 Asia Pacific
9.2.4 Latin America
9.2.5 Middle East & Africa (MEA)
9.3 Market Attractiveness Analysis by Region
Chapter 10 Coronavirus Disease (COVID-19) Impact
10.1 Introduction
10.2 Current & Future Impact Analysis
10.3 Economic Impact Analysis
10.4 Government Policies
10.5 Investment Scenario
Chapter 11 North America Flow Cytometry System Analysis and Forecast
11.1 Introduction
11.2 North America Flow Cytometry System Market Size Forecast by Country
11.2.1 U.S.
11.2.2 Canada
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 North America Flow Cytometry System Market Size Forecast By Technology
11.6.1 Cell-based Flow Cytometry
11.6.2 Bead-based Flow Cytometry
11.7 Basis Point Share (BPS) Analysis By Technology
11.8 Absolute $ Opportunity Assessment By Technology
11.9 Market Attractiveness Analysis By Technology
11.10 North America Flow Cytometry System Market Size Forecast By Product and Service
11.10.1 Reagents and Consumables
11.10.2 Instruments
11.10.2.1 Cell Analyzers
11.10.2.2 Cell Sorters
11.10.3 Services
11.10.4 Software
11.10.5 Accessories
11.11 Basis Point Share (BPS) Analysis By Product and Service
11.12 Absolute $ Opportunity Assessment By Product and Service
11.13 Market Attractiveness Analysis By Product and Service
11.14 North America Flow Cytometry System Market Size Forecast By Application
11.14.1 Research Applications
11.14.1.1 Pharmaceuticals and Biotechnology
11.14.1.2 Immunology
11.14.1.3 Cell Sorting
11.14.1.4 Apoptosis
11.14.1.5 Cell Cycle Analysis
11.14.1.6 Cell Viability
11.14.1.7 Cell Counting
11.14.1.8 Other
11.14.2 Clinical Applications
11.14.2.1 Cancer Diagnostics
11.14.2.2 Hematology
11.14.2.3 Immunodeficiency Diseases
11.14.2.4 Organ Transplantation
11.14.2.5 Other Clinical Applications
11.14.3 Industrial Applications
11.15 Basis Point Share (BPS) Analysis By Application
11.16 Absolute $ Opportunity Assessment By Application
11.17 Market Attractiveness Analysis By Application
11.18 North America Flow Cytometry System Market Size Forecast By End-user
11.18.1 Commercial Organizations
11.18.2 Hospitals
11.18.3 Academic Institutes
11.18.4 Clinical Testing Labs
11.19 Basis Point Share (BPS) Analysis By End-user
11.20 Absolute $ Opportunity Assessment By End-user
11.21 Market Attractiveness Analysis By End-user
Chapter 12 Europe Flow Cytometry System Analysis and Forecast
12.1 Introduction
12.2 Europe Flow Cytometry System Market Size Forecast by Country
12.2.1 Germany
12.2.2 France
12.2.3 Italy
12.2.4 U.K.
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Europe Flow Cytometry System Market Size Forecast By Technology
12.6.1 Cell-based Flow Cytometry
12.6.2 Bead-based Flow Cytometry
12.7 Basis Point Share (BPS) Analysis By Technology
12.8 Absolute $ Opportunity Assessment By Technology
12.9 Market Attractiveness Analysis By Technology
12.10 Europe Flow Cytometry System Market Size Forecast By Product and Service
12.10.1 Reagents and Consumables
12.10.2 Instruments
12.10.2.1 Cell Analyzers
12.10.2.2 Cell Sorters
12.10.3 Services
12.10.4 Software
12.10.5 Accessories
12.11 Basis Point Share (BPS) Analysis By Product and Service
12.12 Absolute $ Opportunity Assessment By Product and Service
12.13 Market Attractiveness Analysis By Product and Service
12.14 Europe Flow Cytometry System Market Size Forecast By Application
12.14.1 Research Applications
12.14.1.1 Pharmaceuticals and Biotechnology
12.14.1.2 Immunology
12.14.1.3 Cell Sorting
12.14.1.4 Apoptosis
12.14.1.5 Cell Cycle Analysis
12.14.1.6 Cell Viability
12.14.1.7 Cell Counting
12.14.1.8 Other
12.14.2 Clinical Applications
12.14.2.1 Cancer Diagnostics
12.14.2.2 Hematology
12.14.2.3 Immunodeficiency Diseases
12.14.2.4 Organ Transplantation
12.14.2.5 Other Clinical Applications
12.14.3 Industrial Applications
12.15 Basis Point Share (BPS) Analysis By Application
12.16 Absolute $ Opportunity Assessment By Application
12.17 Market Attractiveness Analysis By Application
12.18 Europe Flow Cytometry System Market Size Forecast By End-user
12.18.1 Commercial Organizations
12.18.2 Hospitals
12.18.3 Academic Institutes
12.18.4 Clinical Testing Labs
12.19 Basis Point Share (BPS) Analysis By End-user
12.20 Absolute $ Opportunity Assessment By End-user
12.21 Market Attractiveness Analysis By End-user
Chapter 13 Asia Pacific Flow Cytometry System Analysis and Forecast
13.1 Introduction
13.2 Asia Pacific Flow Cytometry System Market Size Forecast by Country
13.2.1 China
13.2.2 Japan
13.2.3 South Korea
13.2.4 India
13.2.5 Australia
13.2.6 South East Asia (SEA)
13.2.7 Rest of Asia Pacific (APAC)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Asia Pacific Flow Cytometry System Market Size Forecast By Technology
13.6.1 Cell-based Flow Cytometry
13.6.2 Bead-based Flow Cytometry
13.7 Basis Point Share (BPS) Analysis By Technology
13.8 Absolute $ Opportunity Assessment By Technology
13.9 Market Attractiveness Analysis By Technology
13.10 Asia Pacific Flow Cytometry System Market Size Forecast By Product and Service
13.10.1 Reagents and Consumables
13.10.2 Instruments
13.10.2.1 Cell Analyzers
13.10.2.2 Cell Sorters
13.10.3 Services
13.10.4 Software
13.10.5 Accessories
13.11 Basis Point Share (BPS) Analysis By Product and Service
13.12 Absolute $ Opportunity Assessment By Product and Service
13.13 Market Attractiveness Analysis By Product and Service
13.14 Asia Pacific Flow Cytometry System Market Size Forecast By Application
13.14.1 Research Applications
13.14.1.1 Pharmaceuticals and Biotechnology
13.14.1.2 Immunology
13.14.1.3 Cell Sorting
13.14.1.4 Apoptosis
13.14.1.5 Cell Cycle Analysis
13.14.1.6 Cell Viability
13.14.1.7 Cell Counting
13.14.1.8 Other
13.14.2 Clinical Applications
13.14.2.1 Cancer Diagnostics
13.14.2.2 Hematology
13.14.2.3 Immunodeficiency Diseases
13.14.2.4 Organ Transplantation
13.14.2.5 Other Clinical Applications
13.14.3 Industrial Applications
13.15 Basis Point Share (BPS) Analysis By Application
13.16 Absolute $ Opportunity Assessment By Application
13.17 Market Attractiveness Analysis By Application
13.18 Asia Pacific Flow Cytometry System Market Size Forecast By End-user
13.18.1 Commercial Organizations
13.18.2 Hospitals
13.18.3 Academic Institutes
13.18.4 Clinical Testing Labs
13.19 Basis Point Share (BPS) Analysis By End-user
13.20 Absolute $ Opportunity Assessment By End-user
13.21 Market Attractiveness Analysis By End-user
Chapter 14 Latin America Flow Cytometry System Analysis and Forecast
14.1 Introduction
14.2 Latin America Flow Cytometry System Market Size Forecast by Country
14.2.1 Brazil
14.2.2 Mexico
14.2.3 Rest of Latin America (LATAM)
14.3 Basis Point Share (BPS) Analysis by Country
14.4 Absolute $ Opportunity Assessment by Country
14.5 Market Attractiveness Analysis by Country
14.6 Latin America Flow Cytometry System Market Size Forecast By Technology
14.6.1 Cell-based Flow Cytometry
14.6.2 Bead-based Flow Cytometry
14.7 Basis Point Share (BPS) Analysis By Technology
14.8 Absolute $ Opportunity Assessment By Technology
14.9 Market Attractiveness Analysis By Technology
14.10 Latin America Flow Cytometry System Market Size Forecast By Product and Service
14.10.1 Reagents and Consumables
14.10.2 Instruments
14.10.2.1 Cell Analyzers
14.10.2.2 Cell Sorters
14.10.3 Services
14.10.4 Software
14.10.5 Accessories
14.11 Basis Point Share (BPS) Analysis By Product and Service
14.12 Absolute $ Opportunity Assessment By Product and Service
14.13 Market Attractiveness Analysis By Product and Service
14.14 Latin America Flow Cytometry System Market Size Forecast By Application
14.14.1 Research Applications
14.14.1.1 Pharmaceuticals and Biotechnology
14.14.1.2 Immunology
14.14.1.3 Cell Sorting
14.14.1.4 Apoptosis
14.14.1.5 Cell Cycle Analysis
14.14.1.6 Cell Viability
14.14.1.7 Cell Counting
14.14.1.8 Other
14.14.2 Clinical Applications
14.14.2.1 Cancer Diagnostics
14.14.2.2 Hematology
14.14.2.3 Immunodeficiency Diseases
14.14.2.4 Organ Transplantation
14.14.2.5 Other Clinical Applications
14.14.3 Industrial Applications
14.15 Basis Point Share (BPS) Analysis By Application
14.16 Absolute $ Opportunity Assessment By Application
14.17 Market Attractiveness Analysis By Application
14.18 Latin America Flow Cytometry System Market Size Forecast By End-user
14.18.1 Commercial Organizations
14.18.2 Hospitals
14.18.3 Academic Institutes
14.18.4 Clinical Testing Labs
14.19 Basis Point Share (BPS) Analysis By End-user
14.20 Absolute $ Opportunity Assessment By End-user
14.21 Market Attractiveness Analysis By End-user
Chapter 15 Middle East & Africa (MEA) Flow Cytometry System Analysis and Forecast
15.1 Introduction
15.2 Middle East & Africa (MEA) Flow Cytometry System Market Size Forecast by Country
15.2.1 Saudi Arabia
15.2.2 South Africa
15.2.3 UAE
15.2.4 Rest of Middle East & Africa (MEA)
15.3 Basis Point Share (BPS) Analysis by Country
15.4 Absolute $ Opportunity Assessment by Country
15.5 Market Attractiveness Analysis by Country
15.6 Middle East & Africa (MEA) Flow Cytometry System Market Size Forecast By Technology
15.6.1 Cell-based Flow Cytometry
15.6.2 Bead-based Flow Cytometry
15.7 Basis Point Share (BPS) Analysis By Technology
15.8 Absolute $ Opportunity Assessment By Technology
15.9 Market Attractiveness Analysis By Technology
15.10 Middle East & Africa (MEA) Flow Cytometry System Market Size Forecast By Product and Service
15.10.1 Reagents and Consumables
15.10.2 Instruments
15.10.2.1 Cell Analyzers
15.10.2.2 Cell Sorters
15.10.3 Services
15.10.4 Software
15.10.5 Accessories
15.11 Basis Point Share (BPS) Analysis By Product and Service
15.12 Absolute $ Opportunity Assessment By Product and Service
15.13 Market Attractiveness Analysis By Product and Service
15.14 Middle East & Africa (MEA) Flow Cytometry System Market Size Forecast By Application
15.14.1 Research Applications
15.14.1.1 Pharmaceuticals and Biotechnology
15.14.1.2 Immunology
15.14.1.3 Cell Sorting
15.14.1.4 Apoptosis
15.14.1.5 Cell Cycle Analysis
15.14.1.6 Cell Viability
15.14.1.7 Cell Counting
15.14.1.8 Other
15.14.2 Clinical Applications
15.14.2.1 Cancer Diagnostics
15.14.2.2 Hematology
15.14.2.3 Immunodeficiency Diseases
15.14.2.4 Organ Transplantation
15.14.2.5 Other Clinical Applications
15.14.3 Industrial Applications
15.15 Basis Point Share (BPS) Analysis By Application
15.16 Absolute $ Opportunity Assessment By Application
15.17 Market Attractiveness Analysis By Application
15.18 Middle East & Africa (MEA) Flow Cytometry System Market Size Forecast By End-user
15.18.1 Commercial Organizations
15.18.2 Hospitals
15.18.3 Academic Institutes
15.18.4 Clinical Testing Labs
15.19 Basis Point Share (BPS) Analysis By End-user
15.20 Absolute $ Opportunity Assessment By End-user
15.21 Market Attractiveness Analysis By End-user
Chapter 16 Competition Landscape
16.1 Flow Cytometry System Market: Competitive Dashboard
16.2 Global Flow Cytometry System Market: Market Share Analysis, 2020
16.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
16.3.1 Agilent Technologies, Inc.
16.3.2 Apogee Flow Systems
16.3.3 Beckman Coulter, Inc.
16.3.4 Becton, Dickinson and Company
16.3.5 Bio-Rad Laboratories, Inc.
16.3.6 bioMérieux S.A.
16.3.7 Cytek Biosciences
16.3.8 Cytonome/ST LLC
16.3.9 Enzo Life Sciences, Inc.
16.3.10 GE Healthcare
16.3.11 Life Technologies Corporation
16.3.12 Luminex Corporation
16.3.13 Mechatronics
16.3.14 Merck KGaA
16.3.15 Miltenyi Biotec GmbH
16.3.16 Sony Biotechnology, Inc.
16.3.17 Stratedigm, Inc.
16.3.18 Sysmex Partec GmbH
16.3.19 Takara Bio Inc.
16.3.20 Thermo Fisher Scientific, Inc.